Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 8-9, Août-Septembre 2004
Page(s) 727 - 729
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2004208-9727
Publié en ligne 15 août 2004
  1. Dormandy JA, Rutherford, RB. Management of peripheral arterial disease (PAD). TransAtlantic inter-society consensus (TASC) working group. J Vasc Surg 2000; 31 : S1–296.
  2. The ICAI Group. Long-term mortality and its predictors in patients with critical leg ischaemia. The study group of criticial chronic ischemia of the lower extremities. Eur J Vasc Endovasc Surg 1997; 14 : 91–5.
  3. Isner JM, Pieckzek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischaemic limb. Lancet 1996; 348 : 370–4.
  4. Baumgartner I, Pieckzek A, Manor O. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical leg ischemia. Circulation 1998; 97 :1114–23.
  5. Shyu KG, Chang H, Wang BW, Kuan P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med 2003; 114 : 85–92.
  6. Comerota AJ, Throm RC, Miller KA, et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia : preliminary results of a phase I trial. J Vasc Surg 2002; 35 : 930–6.
  7. Freedman SB, Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 2002; 136 : 54–71.
  8. Losordo DW, Dimmeler S. Therapeutic angiogenesis and veasculogenesis for ischemic disease. Part I : angiogenic cytokines. Circulation 2004; 109 : 2487–91.
  9. Krais T, Muller B. Iloprost in pheripheral vascular disease. Cardiovasc Drug Rev 1991; 9 : 158–71.
  10. Lederman RJ, Mendelsohn FO, Anderson RD, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study) : a randomized trial. Lancet 2002; 359 : 2053–8.
  11. Takeshita S, Isshiki T, Ochiai M, et al. Endothelium-dependent relaxation of collaterals micorvessels after intramuscular gene transfer of vascular endothelium growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98 : 1261–3.
  12. Tsurimi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94 : 3281–90.
  13. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275 : 964–7.
  14. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85 : 221–8.
  15. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc Natl Acad Sci USA 2000; 97 : 3422–7.
  16. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105 : 1527–36.
  17. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103 : 897–95.
  18. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II : cell based therapies. Circulation 2004; 109 : 2692–7.
  19. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106 : 2019–25.
  20. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells : a pilot study and a randomised controlled trial. Lancet 2002; 360 : 427–35.
  21. Higashi Y, Kimura M, Hara K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004; 109 : 1215–8.
  22. Huang PP, Li SZ, Han MZ, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost 2004; 91 : 606–9.
  23. Wollert KC, Meyer GP, Lotz J, et al. Randomized controlled clinical trial of intracoronary autologous bone marrow cell transfer post myocardial infarction. Circulation 2003; 108 : 2723 (abstract).
  24. Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363 : 783–4.
  25. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction : the MAGIC cell randomised clinical trial. Lancet 2004; 363 : 751–6.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.